CClinicalTrials.gg
CompletedNCT06856915Updated Mar 23, 2026

Effects of Home-based Respiratory Muscle Training Progamme in Individuals With Ischemic Heart Disease

An interventional study of Inspiratory muscle training and Combined inspiratory and expiratory muscle training in Ischemic Heart Disease, sponsored by Universidad Complutense de Madrid. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Universidad Complutense de Madrid · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main objective of the present study is to verify whether respiratory muscle training programme (IMT+EMT; included both inspriratory and expiratory muscles), applied by telerehabilitation, is an effective intervention (versus placebo and versus inspiratory muscle training in isolation (IMT)) in improving quality of life, cardiopulmonary function and physical and psychological state in people with ischemic heart disease. In addition, the aim is to determine whether respiratory muscle training (IMT or IMT+EMT) is effective in enhancing the results obtained by a conventional cardiac rehabilitation programme on the aforementioned variables.

02

Conditions studied

  • Ischemic Heart Disease

Browse trials for

Keywords

  • Respiratory muscle training
  • Cardiac rehabilitation
  • Quality of Life
  • cardiopulmonary function
  • physical state
  • psychological state
  • Telerehabilitation
03

In context

Myocardial Ischemia

3,233 studies on the registry are indexed under Myocardial Ischemia; 396 are open to participants now.

This study's enrollment of 104 is below the median of 120 across 1,895 interventional studies indexed under Myocardial Ischemia.

Browse Myocardial Ischemia studies →

Lead sponsor

Universidad Complutense de Madrid is the lead sponsor of 200 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Presence of ischemic heart disease
  • Age 18 years or older
  • Cardiovascular clinical stability

Exclusion criteria

Exclusion Criteria:

  • Any condition that contraindicate exercise training
  • Inability to close the lips to hold the training device's mouthpiece (e.g., facial paralysis)
  • Previous participation in a rehabilitation programme within the last 3 months
  • Pregnancy
  • Inability to adhere to remote monitoring
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
104 participants (actual)

Study arms

  • Active comparator
    Inspiratory muscle training group + Exercise training

    Participants in this group will perform a home-based inspiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)

    Other: Inspiratory muscle training · Other: Conventional cardiac rehabilitation programme

  • Sham comparator
    Inspiratory muscle training sham group + Exercise training

    Participants in this group will perform a home-based sham inspiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)

    Other: Sham inspiratory muscle training · Other: Conventional cardiac rehabilitation programme

  • Experimental
    Inspiratory and expiratory muscle training group + Exercise training

    Participants in this group will perform a home-based inspiratory and expiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)

    Other: Combined inspiratory and expiratory muscle training · Other: Conventional cardiac rehabilitation programme

  • Sham comparator
    Inspiratory and expiratory muscle training Sham group + Exercise training

    Participants in this group will perform a home-based sham inspiratory and expiratory muscle training programme (8 weeks) by telerehabilitation and after a center-based conventional cardiovascular exercise programme (8 weeks)

    Other: Sham combined inspiratory and expiratory muscle training · Other: Conventional cardiac rehabilitation programme

Interventions

  • OtherInspiratory muscle training

    Participants will engage in inspiratory muscle training programme at home using an inspiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.

  • OtherCombined inspiratory and expiratory muscle training

    Participants will engage in inspiratory+expiratory muscle training programme at home using an inspiratory+expiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.

  • OtherSham inspiratory muscle training

    Participants will engage in sham inspiratory muscle training programme at home using a sham inspiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.

  • OtherSham combined inspiratory and expiratory muscle training

    Participants will engage in sham inspiratory+expiratory muscle training programme at home using a sham inspiratory+expiratory muscle training threshold device . This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided three times per week by telerehabilitation.

  • OtherConventional cardiac rehabilitation programme

    Following the respiratory muscle training programme, participants will transition to a center-based cardiovascular exercise programme conducted twice weekly for eight weeks.

06

What researchers measure

Primary outcomes

  1. Health related quality of life

    EuroQol-five-dimensional Questionnaire A numerical value represented Health state as EQ-5D 'index values' or 'index scores' reflecting how good or bad a health state is. The VAS is a scale from 0 (worst imaginable health state) to 100 (best imaginable health state).

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

Secondary outcomes

  1. Modified Medical Research Council Dyspnoea Scale

    The modified Medical Research Council (mMRC) assess the degree of functional disability due to dyspnoea. The mMRC breathlessness scale ranges from grade 0 to 4. Higher scores mean a worse dyspnoea.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  2. Fatigue

    Multidimensional Fatigue Inventory (MFI-17) The MFI is a valid and reliable instrument for assessing fatigue severity. It consists in 17 items ranked from 1 to 5, the maximun value is 85 points and the minimum 17 points. Higher scores mean a worse fatigue.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  3. Cardiopulmonary function: level of exercise capacity

    Exercise capacity will be measured using a Cardiopulmonary exercise testing (CPET) that precisely defines maximum exercise capacity through measurement of peak oxygen uptake. The following parameters will be acquired by breath-by-breath analysis using an automated gas analyzer: minute ventilation rate; oxygen consumption (VO2); carbon dioxide production (VCO2); and the other variables of to assess aerobic capacity and to identify potential limiting factors. An electrocardiogram and blood pressures will be recorded at rest, throughout exercise and during recovery.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  4. Strength and endurance of the lower limbs

    1 minute sit to stand

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  5. Upper limb strenght

    Upper limb muscle strength (handgrip force) will be assessed using a hand-held dynamometer. Three measurements will be performed for each hand, alternating sides, with the elbow at 90° flexion. The best value will be recorded in kilogrames.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  6. Respiratory muscle strength

    Maximal inspiratory preassure and Maximal expiratory preassure

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  7. Inspiratory muscle endurance

    Inspiratory muscle endurance will be assed by an incremental load test that required subjects to breathe against inspiratory threshold loads that were increased each minute by 10% of baseline PI,max until voluntary task failure muscle endurance test. Inspiratory muscle endurance was defined as the PI,max sustained for a minimum of 1 min.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

  8. Anxiety and depression levels

    The Hospital Anxiety and Depression Scale (HADS) is a self-assessment questionnaire for detecting states of anxiety and depression. The HADS questionnaire has seven items each for depression and anxiety subscales. Scoring for each item ranges from zero to three, with three denoting highest anxiety or depression level.

    Time frame: Pre -intervention, at the end of the respiratory muscle training (8 weeks) and post intervention(16 weeks)

07

Study locations

1 site
  • Departamento de Radiología, Rehabilitación y Fisioterapia, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid
    Madrid, Madrid 28040, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06856915
Lead sponsor
Universidad Complutense de Madrid
Collaborators
Instituto de Salud Carlos III, Instituto de Investigación Sanitaria Hospital Clínico San Carlos, European Regional Development Fund, Hospital Universitario 12 de Octubre
Responsible party
Ibai López de Uralde Villanueva (Tenure-track professor with a PhD in the Department of Radiology, Physiotherapy and Rehabilitation, Universidad Complutense de Madrid) — Principal investigator
First posted
Mar 4, 2025
Start date
May 1, 2025
Primary completion
Feb 6, 2026
Completion
Feb 6, 2026
Last update
Mar 23, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion